Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3‐4aN0M0 compared to cT2N0M0 bladder cancer von Hermans, T.J.N., Voskuilen, C.S., Deelen, M., Mertens, L.S., Horenblas, S., Meijer, R.P., Boormans, J.L., Aben, K.K., Heijden, M.S., Pos, F.J., Wit, R., Beerepoot, L.V., Verhoeven, R.H.A., Rhijn, B.W.G.

Volltext

Authors’ response to Letter to the Editor “Don’t forget Arnhem” von Voskuilen, C.S., Bosschieter, J., Nieuwenhuijzen, J.A., van Rhijn, B.W.G.

Volltext

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment von Pouessel, D., Neuzillet, Y., Mertens, L.S., van der Heijden, M.S., de Jong, J., Sanders, J., Peters, D., Leroy, K., Manceau, A., Maille, P., Soyeux, P., Moktefi, A., Semprez, F., Vordos, D., de la Taille, A., Hurst, C.D., Tomlinson, D.C., Harnden, P., Bostrom, P.J., Mirtti, T., Horenblas, S., Loriot, Y., Houédé, N., Chevreau, C., Beuzeboc, P., Shariat, S.F., Sagalowsky, A.I., Ashfaq, R., Burger, M., Jewett, M.A.S., Zlotta, A.R., Broeks, A., Bapat, B., Knowles, M.A., Lotan, Y., van der Kwast, T.H., Culine, S., Allory, Y., van Rhijn, B.W.G.

Volltext

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE tr... von Stockem, C F, Mellema, J J J, van Rhijn, B W G, Boellaard, T N, van Montfoort, M L, Balduzzi, S, Boormans, J L, Franckena, M, Meijer, R P, Robbrecht, D G J, Suelmann, B B M, Schaake, E E, van der Heijden, M S

Volltext

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer von van der Vos, K. E., Vis, D. J., Nevedomskaya, E., Kim, Y., Choi, W., McConkey, D., Wessels, L. F. A., van Rhijn, B. W. G., Zwart, W., van der Heijden, M. S.

Volltext

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer von Ripping, T M, Rammant, E, Witjes, J A, Aaronson, N K, van Hemelrijck, M, van Hoogstraten, L M C, Kiemeney, L A, Aben, K K H

Volltext

Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy: a nationwide study of 5417... von van Hoogstraten, L. M. C., van Gennep, E. J., Kiemeney, L. A. L. M., Witjes, J. A., Voskuilen, C. S., Deelen, M., Mertens, L. S., Meijer, R. P., Boormans, J. L., Robbrecht, D. G. J., Beerepoot, L. V., Verhoeven, R. H. A., Ripping, T. M., van Rhijn, B. W. G., Aben, K. K. H., Hermans, T. J. N.

Volltext

Prediction of early (30-day) and late (30–90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades von Korbee, M. L., Voskuilen, C. S., Hendricksen, K., Mayr, R., Wit, E. M., van Leeuwen, P. J., Horenblas, S., Meinhardt, W., Burger, M., Bex, A., van der Poel, H. G., van Rhijn, B. W. G.

Volltext

Short-term outcome after cystectomy: comparison of early oral feeding in an enhanced recovery protocol and feeding using Bengmark nasojejunal tube von Voskuilen, C. S., van de Putte, E. E. Fransen, der Hulst, J. Bloos-van, van Werkhoven, E., de Blok, W. M., van Rhijn, B. W. G., Horenblas, S., Meijer, R. P.

Volltext

FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy von van de Putte, E. E. Fransen, Vegt, E., Mertens, L. S., Bruining, A., Hendricksen, K., van der Heijden, M. S., Horenblas, S., van Rhijn, B. W. G.

Volltext

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE tr... von Stockem, C. F, Mellema, J. J.J, van Rhijn, B. W.G, Boellaard, T. N, van Montfoort, M. L, Balduzzi, S, Boormans, J. L, Franckena, M, Meijer, R. P, Robbrecht, D. G.J, Suelmann, B. B.M, Schaake, E. E, van der Heijden, M. S

Volltext

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer von Ripping, T. M, Rammant, E, Witjes, J. A, Aaronson, N. K, van Hemelrijck, M, van Hoogstraten, L. M.C, Boormans, J, Goossens, C. A, van der Heijden, A. G, Hulshof, M.C.C.M, van Leenders, G. J.L.H, van Leliveld, A. M, Meijer, R. P, van Moorselaar, R. J.A, Mulder, S. F, Nooter, R. I, Noteboom, J. L, Oddens, J. R, de Reijke, T. M, van Rhijn, B. W.G, van Roermund, J. G.H, Smilde, T. J, Vanderbosch, G. W.J, Wijsman, B. P, Kiemeney, L. A, Aben, K. K.H, BlaZIB Study Group

Volltext

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy von Boström, P.J., Thoms, J., Sykes, J., Ahmed, O., Evans, A., van Rhijn, B.W. G., Mirtti, T., Stakhovskyi, O., Laato, M., Margel, D., Pintilie, M., Kuk, C., Milosevic, M., Zlotta, A.R., Bristow, R.G.

Volltext

Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer von Vis, A N, van Rhijn, B W G, Noordzij, M A, Schröder, F H, van der Kwast, Th H

Volltext

Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk quanticyt von VAN RHIJN, B. W. G, VAN DER POEL, H. G, BOON, M. E, DEBRUYNE, F. M. J, SCHALKEN, J. A, WITJES, J. A

Volltext

Consecutive quantitative cytology in bladder cancer von VAN DER POEL, H. G, VAN RHIJN, B. W. G, PEELEN, P, DEBRUYNE, F. M. J, BOON, M. E, SCHALKEN, J. A

Volltext

Standaard lymfeklierdissectie bij blaascarcinoom: significante verschillen in het aantal gerapporteerde lymfeklieren von Mertens, L.S., Meijer, R.P., Nunnink, C.J.M., Bex, A., van der Poel, H.G., van Rhijn, B.W.G., Wassenaar, A.E., van Werkhoven, E.D., Meinhardt, W., Horenblas, S.

Volltext

High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial von van Dorp, Jeroen, Pipinikas, Christodoulos, Suelmann, Britt B. M., Mehra, Niven, van Dijk, Nick, Marsico, Giovanni, van Montfoort, Maurits L., Hackinger, Sophie, Braaf, Linde M., Amarante, Tauanne, van Steenis, Charlaine, McLay, Kirsten, Daletzakis, Antonios, van den Broek, Daan, van de Kamp, Maaike W., Hendricksen, Kees, de Feijter, Jeantine M., Boellaard, Thierry N., Meijer, Richard P., van der Heijden, Antoine G., Rosenfeld, Nitzan, van Rhijn, Bas W. G., Jones, Greg, van der Heijden, Michiel S.

Volltext

Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient O... von Eckstein, Markus, Matek, Christian, Wagner, Paul, Erber, Ramona, Büttner-Herold, Maike, Wild, Peter J, Taubert, Helge, Wach, Sven, Sikic, Danijel, Wullich, Bernd, Geppert, Carol I, Compérat, Eva M, Lopez-Beltran, Antonio, Montironi, Rodolfo, Cheng, Liang, van der Kwast, Theodorus, Colecchia, Maurizio, van Rhijn, Bas W G, Amin, Mahul B, Netto, George J, Lehmann, Jan, Stöckle, Michael, Junker, Kerstin, Hartmann, Arndt, Bertz, Simone

Volltext

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate von VAN RHIJN, Bas W. G, LURKIN, Irene, RADVANYI, Francois, KIRKELS, Wim J, VAN DER KWAST, Theodorus H, ZWARTHOFF, Ellen C

Volltext